Background Chronic infection with the hepatitis C virus has been reported to cause a wide variety of ophthalmic lesions. The incidence and significance of these lesions in
an unselected population has not been assessed.
Methods
We studied a group of unselected patients with chronic hepatitis C and performed a full ophthalmic examination on each. As a control group we studied patients with chronic hepatitis B infection.
Results In 25 patients with chronic hepatitis C we found no increase in the prevalence of significant ocular disease when compared with a cohort of patients with chronic hepatitis B.
Conclusion Chronic heptatitis C does not cause any marked increase in the incidence of ocular disease. screeningp they were not used in this study.
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Results
The patient characteristics are shown in Table 1 . The results of the ophthalmic assessment for dry eyes is shown in there was no evidence of any significant ocular disease secondary to abnormal tear formation in any patient with HCV.
Discussion
Our study was designed to determine whether there was a high prevalence of clinically significant ocular lesions in patients with uncomplicated chronic HCV infection .
We excluded patients with coexisting cryoglobulinaemia in whom keratoconjunctivitis sicca has been reported, and we did not study patients with other autoimmune disorders. It is therefore possible that in patients with other autoimmune manifestations of chronic HCV infection, ocular lesions may be detected and clinicians should be aware of this possibility.
We studied patients attending the specialist hepatology clinic at a London teaching hospital. It is therefore likely that the patients will have more advanced liver disease than is typical for patients with chronic HCV, and this is borne out by the high prevalence of patients with cirrhotic liver disease in our study. If chronic HCV does cause significant ocular disease, it is more likely to be detected in patients with the more advanced forms of HCV, and our finding that there was no increased prevalence of ophthalmic disease in patients with chronic HCV is likely to be true for patients with less advanced disease. As controls for the HCV-infected patients we chose a group of patients with chronic HBV infection to control for the non-specific effects of liver damage and systemic ill-health, and to ensure that the ophthalmic observer was truly masked as to the patients' diagnosis. The HCV -infected patients tended to be older than the HBV group (although this difference was not significant), and there were more women. Both these differences would be likely to exaggerate any increased tendency towards dry eye in the HCV group as dry eye is more common in women and with increasing age.1S
Early reports linking chronic HCV infection to
Sjogren's syndrome appeared to be confirmed by studies reporting abnormal histological findings in salivary gland biopsies from patients with chronic HCV,S,12
although significantly less than the changes seen in patients with classical Sjogren's syndrome. For this reason dry eye was specifically looked for in this study.
We used a battery of tests that measured symptoms, tear composition (tear film meniscus height and fluorescein instillation test) and corneal and conjunctival injury (fluorescein and Rose Bengal staining). We found no evidence of any clinically relevant tear defects in patients with chronic HCV infection. The high incidence of rapid fluorescein tear film break-up times may indicate a non specific effect of chronic illness or liver disease on tear film quality (but not quantity, as in keratoconjunctivitis sicca), but we found no evidence for a specific increase in the prevalence of dry eyes in patients with chronic Hey.
The absence of symptoms or other signs of dry eyes suggests that any abnormality is unlikely to be clinically significant.
Our study shows that in a population of patients with uncomplicated Hey infection who are likely to be at risk of developing dry eyes (advanced disease, old age, female sex) there is no increased prevalence of keratoconjunctivitis sicca, and screening for ocular disorders in patients with chronic Hey is unnecessary.
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